Diagnosis and treatment of pancreatic primary lymphoma

Huang Zhong-Yue; Fei Jian
July 2008
Journal of US-China Medical Science;Jul2008, Vol. 5 Issue 7, p33
Academic Journal
Primary pancreatic lymphomas (PPL) are extremely rare, comprising less than 2% of all extra-lymphatic lymphomas and only 0.5% of all pancreatic malignancies. PPL present with nonspecific symptoms. Common clinical manifestations include abdominal pain, jaundice, weight lose. Although imaging techniques such as CT is helpful to diagnose, it is still difficult to differentiate the condition from other pancreatic disease, especially pancreatic adenocarcinoma. Fine-needle aspiration (FNA) or open biopsy is the only way to confirm the diagnosis. There is no consensus about the treatment of PPL, usually with chemotherapy, radiotherapy, and (or) operation. PPL has a much better prognosis than adenocarcinoma of the pancreas.


Related Articles

  • Breast systemic follicular lymphoma in a man: a case report. La Mantia, Elvira; Cantile, Monica; Liquori, Giuseppina; Di Bonito, Maurizio; De Chiara, Annarosaria; D'Aiuto, Massimiliano; Pannone, Giuseppe; Franco, Renato; Botti, Gerardo; Liguori, Giuseppina // Journal of Medical Case Reports;2012, Vol. 6 Issue 1, p217 

    Introduction: Breast involvement by non-Hodgkin lymphoma is particularly rare in men. We describe the case of a patient with a rapidly growing, painless gynecomastia-like nodule in the left breast. On ultrasonography, the nodule was suspicious for breast carcinoma.Case...

  • Burkitts's lymphoma -- an atypical presentation. Ziade, Farah; von der Weid, Nicolas; Beck-Popovic, Maja; Nydegger, Andreas // BMC Pediatrics;2012, Vol. 12 Issue 1, p113 

    Background: In female adolescents and young adults, malignancies of the genital tract are the most frequent type of cancer, closely followed by Hodgkin's and non-Hodgkin's lymphomas. Case Presentation: We report an unusual case of sporadic Burkitt's lymphoma (BL) presenting with massive...

  • Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma. Cremerius, U.; Fabry, U.; Wildberger, J. E.; Zimny, M.; Reinartz, P.; Nowak, B.; Schaefer, W.; Buell, U.; Osieka, R. // Bone Marrow Transplantation;7/15/2002, Vol. 30 Issue 2, p103 

    Presents a study that investigated the predictive value of sequential fluoro-deoxyglucose (FDG) positron emission tomography (PET) before and after high-dose chemotherapy and autologous stem cell transplantation in patients suffering from non-Hodgkin's lymphoma (NHL). Background on the...

  • Early prediction of response to therapy: the clinical implications in Hodgkin’s and non-Hodgkin’s lymphoma. Kostakoglu, Lale // European Journal of Nuclear Medicine & Molecular Imaging;Aug2008, Vol. 35 Issue 8, p1413 

    The author reflects on early prediction of response to therapy on Hodgkin's and non-Hodgkin's lymphoma (HL). He asserts that fluorodeoxyglucose positron-emission tomography (FDG-PET) is useful when performed after various cycles of therapy in HL and diffuse large B-cell lymphoma. He reveals that...

  • Pulmonary intravascular lymphoma diagnosed by 18-fluorodeoxyglucose positron emission tomography-guided transbronchial lung biopsy in a man with long-term survival: a case report.  // Journal of Medical Case Reports;2011, Vol. 5 Issue 1, p295 

    The article presents case report of a 61-year-old Japanese man who had pulmonary intravascular lymphoma and no computed tomography abnormality. In the case, pulmonary intravascular lymphoma was diagnosed by 18-fluorodeoxyglucose positron emission tomography-guided transbronchial lung biopsy. The...

  • Relapsed large B-cell non-Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Jost, L. // Annals of Oncology;May2007 Supplement 2, Vol. 18, pii57 

    The article presents clinical recommendations from the European Society for Medical Oncology (ESMO) for the diagnosis, treatment and follow-up of relapsed large B-cell non-Hodgkin's lymphoma. Its diagnosis may include a histological report based on the classification and description of World...

  • Pneumomediastinum as a complication to treatment of mediastinal (thymic) large B-cell lymphoma. Pavlisa, G.; Planinc-Peraica, A.; Anic, P.; Kardum-Skelin, I.; Jaksic, B. // Acta Radiologica;Jul2005, Vol. 46 Issue 4, p371 

    Mediastinal (thymic) large B-cell lymphoma (Med-DLBCL) is a subtype of diffuse large B-cell lymphomas (DLBCL) with a typical radiological appearance of bulky anterior mediastinal mass, often with areas of necrosis. We report a case of Med-DLBCL with unusual radiological findings and clinical...

  • Non-Hodgkin Lymphoma. Fox, Christopher; Mead, Adam; Sellar, Rob // Current Medical Literature: Leukemia & Lymphoma;2012, Vol. 20 Issue 1, p26 

    The article provides information on studies on non-Hodgkin lymphoma published in medical journals in 2011. M. Yamaguchi et al provided a phase ll study of a novel, non-cross resistant regimen called SMILE chemotherapy for newly diagnosed stage lV, relapsed or refractory extranodal natural...

  • Primary Lymphoma of the Breast: A Case of Marginal Zone B-Cell Lymphoma. Giron, Gladys L.; Hamlin, Paul A.; Brogi, Edi; Mendez, Jane E.; Sclafani, Lisa // American Surgeon;Aug2004, Vol. 70 Issue 8, p720 

    A case of primary marginal zone B-cell lymphoma in an elderly female patient is presented. Primary breast lymphomas are rare, comprising less than 1 per cent of all breast malignancies. These tumors have no clinical, pathologic, or radiologic pathognomonic features to distinguish them from...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics